HMD Holstov Metabolic Dynamics
← Back to Investigational Systems
TRIVEXA vial
C221H342N46O68

TRIVEXA

Retatrutide

TRIVEXA is presented within HMD as an investigational system for scientific reading and molecular characterization. This profile connects the molecule with related historical and technical documentation within the HMD series.

TypeTriple GIP, GLP-1 and glucagon receptor agonist
Chemical / scientific nameSynthetic 39-amino-acid peptide with complex structural modifications and a lipid side chain intended to prolong exposure.
Molecular formulaC221H342N46O68

Technical profile

This profile is part of a documentary library of investigational systems. It does not constitute a clinical indication, therapeutic recommendation, prescription, commercial availability, or instructions for use.

Related literature

Research dossier

HMD-ED-003 — TRIVEXA Evidence Dossier

Retatrutide · Full Technical Brief. Document viewer for client-facing technical consultation, integrated into the molecular profile of the investigational system.

Technical viewer
HMD-ED-003 — TRIVEXA Evidence Dossier
10 pages · HMD technical reading

Loading dossier...